When will the TO bid come according to this analysis? Why has it not happened already? Would any other competitors such as Bayer, Amgen, Merck and Teva, a past TO bid suitor for SRX, want it?
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%